- Home
- NRXP vs BRNS Comparison
NRXP vs BRNS Comparison
Compare NRXP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | BRNS |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NRXP | BRNS |
|---|---|---|
| Price | $2.10 | $0.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $30.50 | $4.00 |
| AVG Volume (30 Days) | ★ 455.8K | 107.0K |
| Earning Date | 11-17-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $242,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $643.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $1.15 | $0.64 |
| 52 Week High | $6.01 | $2.92 |
Technical Indicators
Market Signals| Indicator | NRXP | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 33.53 |
| Support Level | $2.22 | $0.66 |
| Resistance Level | $2.39 | $0.78 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 3.41 | 8.80 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.